150 related articles for article (PubMed ID: 38743845)
1. Can Hypnotherapy Be Considered a Valuable Component in the Management of Inflammatory Bowel Disease? Insights from a Comprehensive Review.
Mpakogiannis K; Fousekis FS; Katsanos AH; Katsanos KH
Int J Clin Exp Hypn; 2024; 72(3):274-288. PubMed ID: 38743845
[TBL] [Abstract][Full Text] [Related]
2. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease.
Peters SL; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2015 Jun; 41(11):1104-15. PubMed ID: 25858661
[TBL] [Abstract][Full Text] [Related]
3. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
[TBL] [Abstract][Full Text] [Related]
4. Hypnotherapy for Inflammatory Bowel Disease Across the Lifespan.
Szigethy E
Am J Clin Hypn; 2015 Jul; 58(1):81-99. PubMed ID: 26046718
[TBL] [Abstract][Full Text] [Related]
5. The role of hypnotherapy for the treatment of inflammatory bowel diseases.
Moser G
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):601-6. PubMed ID: 24819701
[TBL] [Abstract][Full Text] [Related]
6. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M
Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535
[TBL] [Abstract][Full Text] [Related]
7. Hypnotherapy for treatment of irritable bowel syndrome.
Webb AN; Kukuruzovic RH; Catto-Smith AG; Sawyer SM
Cochrane Database Syst Rev; 2007 Oct; (4):CD005110. PubMed ID: 17943840
[TBL] [Abstract][Full Text] [Related]
8. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.
Peters SL; Yao CK; Philpott H; Yelland GW; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2016 Sep; 44(5):447-59. PubMed ID: 27397586
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome.
Wilson S; Maddison T; Roberts L; Greenfield S; Singh S;
Aliment Pharmacol Ther; 2006 Sep; 24(5):769-80. PubMed ID: 16918880
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
Lövdahl J; Törnblom H; Ringström G; Palsson OS; Simrén M
Aliment Pharmacol Ther; 2022 Jun; 55(12):1501-1511. PubMed ID: 35505463
[TBL] [Abstract][Full Text] [Related]
11. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS).
Lindfors P; Törnblom H; Sadik R; Björnsson ES; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2012 Dec; 47(12):1480-7. PubMed ID: 23094932
[TBL] [Abstract][Full Text] [Related]
12. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
[TBL] [Abstract][Full Text] [Related]
14. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.
Palsson OS
Am J Clin Hypn; 2015 Oct; 58(2):134-58. PubMed ID: 26264539
[TBL] [Abstract][Full Text] [Related]
15. Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases.
Rozich JJ; Holmer A; Singh S
Am J Gastroenterol; 2020 Jun; 115(6):832-840. PubMed ID: 32224703
[TBL] [Abstract][Full Text] [Related]
16. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial.
Roberts L; Wilson S; Singh S; Roalfe A; Greenfield S
Br J Gen Pract; 2006 Feb; 56(523):115-21. PubMed ID: 16464325
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
Lee HH; Choi YY; Choi MG
J Neurogastroenterol Motil; 2014 Apr; 20(2):152-62. PubMed ID: 24840368
[TBL] [Abstract][Full Text] [Related]
18. Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease.
Person H; Keefer L
Curr Gastroenterol Rep; 2019 Mar; 21(4):12. PubMed ID: 30868282
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.
Flik CE; Laan W; Zuithoff NPA; van Rood YR; Smout AJPM; Weusten BLAM; Whorwell PJ; de Wit NJ
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):20-31. PubMed ID: 30473202
[TBL] [Abstract][Full Text] [Related]
20. Hypnotherapy for persons with Irritable Bowel Syndrome: A three-arm randomized controlled trial.
Wan YP; Ng SM
Am J Clin Hypn; 2022 Oct; 65(2):110-135. PubMed ID: 35412965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
